Potent topical steroid

PreclinicalSmall molecule

UUniversity Hospitals Coventry and Warwickshire NHS Trust

Potent topical steroid is one of 19 small molecule programs targeting Transplantation. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

TransplantationWithdrawn

TransplantationPreclinical

Withdrawn

Competition

Competitive Landscape

23 competitors in Transplantation

#DrugCompanyPhaseTrials

Rituxan

Roche

Phase 3

5 2

Atgam

Novartis

Phase 3

5 3

Olumiant

Eli Lilly

Phase 3

1 4

Fludara

Sanofi

Phase 2

14 5

Neupogen

EEastern Cooperative Oncology Group

Phase 3

3 6

Trexall

Jazz Pharmaceuticals

Phase 2

3 7

Cytoxan

BBaxter Healthcare Corporation

Phase 2

13 8

Alkeran

AApotex Inc.

Phase 2

13 9

Actemra

Roche

Phase 2

1 10

Keppra

UCB

Phase 2

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Steroid1 trial

Ocular Pressure in Steroid-treated Dermatology Patients

Terminated·UUniversity Hospitals Coventry and Warwickshire NHS Trust··NCT01759914·25 enrolled

Endothelial Dystrophy1 trial

Investigation of Treatment With Topical Corticosteroid After Posterior Lamellar Corneal Transplantation

Withdrawn·AAarhus University Hospital·Preclinical·NCT01682421

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for Potent topical steroid. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Potent topical steroid compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Potent topical steroid. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — University Hospitals Coventry and Warwickshire NHS Trust company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: UUniversity Hospitals Coventry and Warwickshire NHS Trust

Potent topical steroid

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Steroid1 trial

Endothelial Dystrophy1 trial

References

Drug Info

Quick Facts

Related News